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Abstract 
Introduction: Systemic lupus erythematosus (SLE) is a disabling, chronic, multisystem 
autoimmune disease that occurs in women of childbearing years (15-40) and spans a lifetime. 
Little is known about the relevance that social support has in the context of mental health 
wellbeing for patients with SLE.  Physicians may be an adequate source of support when it 
comes to SLE. Since there are arrays of triggers for depression, there is a need to understand the 
SLE experience to help with disease management. 
Objective: To examine the association of social support from a physician and the mental health 
wellbeing of SLE patients.  
Methods: We examined 652 SLE patients from the Georgians Organized Against Lupus 
(GOAL) cohort. Descriptive analysis was performed. Univariate analysis was performed to 
examine the associations of the main dependent variables (Short Form Health Survey (SF-12) 
and Patient Health Questionnaire (PHQ-9)) and each independent variable. Both, univariate and 
multivariate logistic regression analyses were conducted to determine associations between 
selected characteristics and main independent variables (emotional or social support and social 
support from a physician) with the categorized mental component score and PHQ9 depression 
score, individually and together. Ninety-five percent confidence intervals were used to determine 
statistical significance.  
Results: SLE patients who perceived having enough emotional/social support were found to 
have an overall better mental health status than the average American, and 64% less likely to be 
depressed compared to patients who did not have enough emotional/social support. Patients who 
were categorized as having social support from a physician were found to be in poorer mental 
health statuses, as measured by the MCS SF-12 and PHQ9 depression score. 
Conclusion: The findings of this study show that emotional or social support is associated with a 
better mental health well-being for SLE patients.  SLE patients who have enough emotional or 
social support were found to have above normal general mental health and less depression. This 
study did not show any direct associations between physician social support and mental health 
wellbeing.   
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CHAPTER 1 
INTRODUCTION 
 
The salience of social support for patients with chronic diseases gains increased 
recognition in public health for the last two decades.  Notably, it has become of interest to other 
academic disciplines including behavioral medicine and health psychology (Mazzoni & 
Cicognani, 2011; Lincoln & Chae, 2012; Seawell & Danoff-Burg, 2004).  However, little is 
known about the relevance that social support has in the context of mental health well-being for 
patients with systemic lupus erythematosus (Breslau, Kendler, Su, Gaxiola-Aguilar, & Kessler).  
SLE is a disabling, chronic, multisystem autoimmune disease that occurs most often in women of 
childbearing years and spans a lifetime (Beusterien et al., 2013).  Due to the unpredictability of 
symptom manifestations and SLE mimicking other common diseases, SLE is difficult to 
diagnose (Robinson, Cook & Currie 2010).  Patients often endure several years of multiple, often 
different, doctor visits before receiving a proper diagnosis.  An efficient support system for 
patients with SLE is needed in order to offset the mental health deterioration that accompanies 
the physical damage due to such a chronic disease (Pennix et al., 1997). 
In general, chronic illnesses are ranked as a major cause of death and disability in the 
United States of America (Kung, Xu & Murphy, 2005).  For patients with a chronic disease, 
depression is one of the most common complications (Moussavi et al., 2007).  The psychosocial 
experiences SLE offers the opportunity to explore the unmet needs of patients in terms of 
psychological needs.  SLE patients often have to deal with the unpredictability of the disease 
while dealing with everyday stressors.  There is a need to understand SLE experience in order to 
manage the disease effectively (Beckerman & Sarracco, 2012). 
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In chronic disease management, social support has been found to affect functionality and 
pain, as well as psychosocial feelings of isolation (Brooks, Andrade, Middleton, & Wallen, 
2014).  The findings of Brooks et al. (2014) suggest that social support is beneficial to SLE 
patients’ general well-being.  The findings of Mazzoni and Cicognani (2011) corroborate 
previous findings on the benefits of social support and how more support can provide better 
health.  However, the results of Brooks et al., suggest that the type of support (emotional, 
informational, or institutional), rather than the amount, is most beneficial in improving patient’s 
health outcomes. Understanding whether support from a family member, friend or a physician is 
more associated with better well-being of patients with a chronic disease is critical. The overall 
relationship between social support and well-being of SLE patients is relatively 
broad; researchers have not developed the best way to understand which aspects of social support 
are critical for SLE patients (Zheng et al., 2009). 
Since previous studies show evidence that any type social support is relevant to the 
patient’s improved health outcome (Brooks et al., 2014), this study specifically examines 
emotional social support.  This study hypothesizes that the emotional support from a physician is 
a good approach to meeting the health needs of SLE patients.  Therefore, this study examines the 
role a physician plays in the emotional support of SLE patients.  Specifically, this study 
investigates the effect of social support in the form of emotional support from a physician on the 
mental health well-being of SLE patients. 
To understand SLE patient mental health well-being, we utilized the mental health 
component score from the Short Form Health Survey (SF-12) instrument and a depression 
screener from the Patient Health Questionnaire (PHQ-9) instrument. The central questions 
addressed in this study are: 
11 
 
1.  Is emotional and social support (from any source) associated with mental health of SLE 
patients? 
2.  What is the association between social supports from a physician mental health of SLE patient? 
This study uses two different measures of social support and patient well-being to (a) further 
corroborate previous literature about the efficacy of social support on patient well-being (b) 
operationalize social support from physicians, and (c) provide empirical evidence to physicians on 
the benefits of serving as another source of social support for patients. 
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CHAPTER 2 
LITERATURE REVIEW 
Systemic Lupus Erythematosus 
SLE has been defined as a disabling, chronic, multisystem autoimmune disease with high 
morbidity and mortality rates (Beusterien et al., 2013; Sacks, Helmick, Langmaid, & Sniezek 
2002).  SLE has periods of symptom remission, flares, and progression; a flare is the 
exacerbation of previous symptoms and progression is the worsening of newer symptoms 
(Robinson et al., 2010). Common symptoms of lupus include extreme fatigue, kidney problems, 
painful or swollen joints and skin rashes (Ehrenstein & Isenberg, 2004).  SLE flares were found 
to be triggered by several occurrences: ultraviolet light exposure, sulfa medications, infections, 
exhaustion, pregnancy and stress (Ferenkeh-Koroma, 2012).  Although the etiology of this 
disease has eluded researchers for years, it has been theorized that genetics, environment and 
hormonal factors contribute to disease manifestation (Robinson et al.). 
Despite the ambiguous etiology of SLE, the immunology of the illness is definitively 
understood.  The immune system is generally responsible for fighting off viruses, bacteria, and 
germs (foreign intruders) but has proven to not properly work for SLE patients (Rahman and 
Isenberg 2008).  The body’s natural alert system, inflammation, is triggered when a foreign 
intruder has invaded, and the body produces proteins or antibodies to eliminate the threat.  
Symptoms associated with SLE occur because of the presence of autoantibodies (self-attacking 
antibodies) that are programmed to attack and destroy healthy tissue, ribonucleoproteins, 
chromatin (chromosomal material), and phospholipids (Arbuckle et al., 2003; Rigby & Vinuesa, 
2008).  Symptom manifestations are preceded by autoantibody productions and suggest direct 
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causality in end-organ disease (Arbuckle et al., 2003; Rigby & Vinuesa, 2008).  SLE is a 
contributory factor in inflammation and tissue damage in any organ of the body (Ferenkeh-
Koroma, 2012) 
SLE manifestations include varying symptom features that comprise renal, dermatologic, 
neurological, and hematological involvement (Robinson, 2011).  Since SLE symptoms have been 
found to mimic other common diseases and there is no definitive test to diagnosis SLE, the 
American College of Rheumatology developed a set of criteria widely used for diagnosis 
(Hochberg, 1997).  In order for a patient to be positively diagnosed with SLE, four of the 
following 11 criteria must be met: malar rash, discoid rash, photosensitivity, oral ulcers, non-
erosive arthritis, pleuritic or pericarditis, renal disorder, neurologic disorder, hematologic 
disorder, immunologic disorder, and/or positive antinuclear antibodies (ANAs) (Hochberg 1997).  
A positive ANA test is a common standard for diagnosing SLE, but it is also associated with 
other connective tissue diseases like Sjögren's syndrome, scleroderma, and rheumatoid arthritis 
(Gill et al., 2003; Robinson et al., 2010). Even though the patient may manifest several of the 
symptoms of SLE, they can fail to meet the criteria for SLE diagnosis (Wallace 2008). 
 
SLE and Health Well-being 
The World Health Organization defines health as “a state of complete physical, mental 
and social well-being and not merely the absence of disease or infirmity” (World Health 
Organization [WHO], 1946).  For a patient with SLE, disease activity and organ damage serve as 
a proxy for poor well-being.  Recent studies have attempted to define SLE in the context of the 
WHO definition of overall wellness.  Hence, there has been a recent surge in physical, mental 
14 
 
and psychosocial health research in SLE (Seawell & Danoff-Burg, 2004).  All three components 
of health are interrelated; treating physical health alone will not yield a salubrious well-being.  
Since the symptoms of SLE can take many years to manifest, disease management should 
promote a healthy mental and social well-being (Beckerman & Sarracco, 2012). 
 
Socio-economic Background of SLE 
SLE most frequently occurs in young women of color, particularly African Americans 
(D’Cruz 2006).  Females have been found to be nine times more likely to develop SLE than 
males; however, males who develop SLE tend to have more severe disease activity than their 
female counterparts (Kasitanon, Magder, & Petri, 2006).  African American women are 3-4 
times more likely to develop SLE and 3-6 times more likely to develop severe 
complications such as multi-organ damage, end-stage renal disease, or cardiovascular disease- at 
an early age, resulting in higher overall mortality rates, compared to their Caucasian counterparts 
(Drenkard et al., 2014; Gallop et al., 2012).  Although evidence suggests that SLE disease 
activity and damage are linked to ethnicity, it is not well known if this association is primarily 
due to a patient’s social-economic status (Moses, Wiggers, Nicholas, & Cockburn) or is related 
to genotypic disease variations that exist amongst various ethnic groups (Jolly, Mikolaitis, 
Shakoor, Fogg, & Block, 2010). 
In addition to the racial disparity in SLE, patient well-being for African Americans 
is unequal to Caucasian patients due to differences in SES.  In the United States, ethnic 
minorities are associated with lower SES statuses as represented by lower levels of education, 
access to health insurance or healthcare, and inadequate housing (González, Toloza, McGwin, & 
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Alarcón, 2013).  Barriers to healthcare are associated with poorer clinical outcomes and the 
combination of these factors, along with general nuances for proper diagnosis, leads to poor 
treatment adherence and less effective treatments (Law et al., 2009). As a result, ethnic 
minorities accrue more organ damage and higher mortality; African Americans with SLE have a 
two-threefold higher risk of death than Caucasians (González et al., 2013).  Although studies on 
depression show that African Americans have lower prevalence rates, African Americans have a 
higher persistence rate and impairment associated with depression compared to Caucasians 
(Breslau, Kendler, Su, Gaxiola-Aguilar, & Kessler, 2005; Dunlop, Song, Manheim, Lyons, & 
Chang, 2003; Lincoln & Chae, 2012; Williams et al., 2007). 
 
Mental Well-being and Depression  
Mental health is a component of overall health as defined by the WHO definition (WHO, 
1946).  Poor mental health is associated with poor overall health promotion.   Recent emphasis 
on mental health has fostered the growth of empirical research identifying the psychosocial 
experiences of SLE patients and providing insight into understanding how to better serve patients 
(Beckerman & Sarracco, 2012).  Since depression is one of the most common psychosocial 
disorders, most patients receive diagnosis and treatment from a primary care physician rather 
than a mental health specialist (World Health Organization [WHO], 2012).  In 2000, it was the 
leading cause of disability and premature mortality in the United States (Lincoln & Chae 2012).  
Depression is chronic and has phases of exacerbation or remission, similar to SLE 
characteristics.  SLE and depression have the potential to inhibit functioning at work, school and 
coping with life, the combined effect they have on patients may be overwhelming.  The findings 
of Philip, Lindner and Lederman (2009) show that the majority (56%) of their study (n=154) has 
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moderate/clinical depression due to the impact of the disease. In another study of SLE patients, a 
positive correlation between emotional states and the disease activity and duration were 
observed, and patients were found to be more susceptible to negative emotions if they presented 
with symptoms (Kulczycka, Sysa-Jedrzejowska, & Robak, 2010). The findings of Beckerman & 
Sarracco (2012) show that loss and coping with uncertainty are the commonalities that pose 
psychosocial challenges for patients with SLE and their families. These findings are in 
concurrence with an earlier study that findings show women with SLE experience acute 
psychosocial distress that is linked to the loss of valued social roles such as being a wife, mother, 
sister, daughter, and friend (Karasz & Ouellette, 1995). 
 
Defining social support 
There are multiple definitions used to conceptualize social support.  One common consensus 
when looking at SLE literature defines social support as “ the existence or availability of people 
on whom we can rely, people who let us know that they care about, value and love us” (Mazzoni 
& Cicognani, pg 1118, 2011).  Another definition of social support refers to a “social network’s 
provision of psychological and material resources intended to benefit an individual’s ability to 
cope with stress” (Cohen, pg 676, 2004).  These definitions address the source of social support.  
Additionally, they introduce conceptual items of support and give a definite directionality of its 
benefit.  These definitions limit the need for social support to only dealing with stress and do not 
account for the possible adverse effects of social support (Shumaker & Brownell, 1984).  This 
study defines social support as “an exchange of resources between at least two individuals 
perceived by the provider or recipient to be intended to enhance the well-being of the recipient” 
(Shumaker & Brownell, pg 13, 1984).  This definition allows social support to not only deal with 
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stress, but opens it up to other mental health issues the recipient may be experiencing; it allows 
for an exchange among at least two participants (Shumaker & Brownell, 1984).   
Despite the variations in social support definition, researchers agree that social support 
has three components: emotional, instrumental, and informational (House & Kahn 1985).  
Emotional support is what people do to make one feel they matter, instrumental support is the 
tangible aid one offers others, and informational support relates to the bestowing of information 
(Shumaker & Brownell, 1984).  Although all three types of social support are positively 
associated with better health outcomes in SLE patients, emotional support is the most widely 
used of the three measures (Brooks et al., 2014; Lincoln & Chae, 2012; Mazzoni & Cicognani, 
2011).  
 
Emotional support 
Emotional support is crucial in helping to alleviate the negative emotions SLE patients 
endure. In the Gallop et al study (2012), SLE patients report having feelings of anger, 
helplessness, depression and incompetence due to SLE; 14% of participants felt too fatigued to 
engage in conversations; 14% of participants also desired to be alone during a flare, affecting 
their social activities and relationships.  However, study participants are able to cope with these 
negative emotions by having a readily available network of interpersonal relationships.  Patients 
perceive networks to be reliable for providing emotional support and readily available during 
periods of pain and disability (Mazzoni & Cicognani, 2011).  The study further suggests 
that SLE support groups are essential to meeting patient needs. An open environment with peers 
of SLE patients is necessary for alleviating negative feelings among study patients. SLE support 
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groups are a primary source of emotional support for enhancing the psychological well-being of 
patients (Ng & Chan, 2007). 
 
Gaps in social support 
There are main drawback to measuring social support in empirical data.  There is a lack of a 
universal definitive measure for social support.  There are many constructs for social 
support measurement; hence it is difficult to draw comparative conclusions.  In Lincoln & Chae 
(2012), social support is a measure of the perceived frequency on how often family members 
make the participant feel loved and cared for, listen to their issues, and express concern for their 
well-being.  In Brooks et al (2014), social support is a measure of the individual’s perception of 
support as it relates to their illness asking “who or what provides your strongest source of social 
support to cope with your illness and related symptoms?”  Zheng et al. (2009) study uses the 
Social Support Rate Scale (SSRS) questionnaire, where higher social support scores indicate a 
better level of social support.  Although use of an objective measure would make analyses 
stronger, the authors of the three studies used their own measure of social support but they all 
suggest that social support is beneficial.   
 
Physicians and Social Support 
A physician’s contribution to the patient’s social network can be overlooked when 
assessing the interpersonal source of support.  The findings of Brooks et al. (2014) show that 
seven individuals claim health professionals are a source of social support but most consider it 
informational support.  When looking at social support from a physician as informational only, 
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patients do not experience the total benefits that come along with emotional support.  Emotional 
support can act as a barrier to negative mental health states like depression, anxiety or stress.  
The findings of Lincoln & Chae (2012) suggest that although social support from physicians is 
enthusiastic in nature, what physician’s extrapolate as necessary for SLE patients is not relevant 
to the patient’s needs.  Since SLE patients report the inability to connect with friends and family 
due to coping with the disease (Beckerman & Sarracco, 2012; Ng & Chan, 2007), SLE patients 
often resort to other source of support.  
Physicians can be a supplemental source of support when it comes to SLE patients.  
Physicians can alleviate feelings of being burdensome because there is no need for reciprocity, 
unlike in familiar relationships that are characterized by an even exchange of helping and 
receiving (Dunkel-Schetter, 1984).  Physicians are able to maintain an ongoing relationship with 
the patients and not be intimidated by the disease activity needs (Shumaker & Brownell, 1984).  
Also, physicians provide expert information in comparison to other sources of social support. 
(Shumaker & Brownell, 1984). 
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CHAPTER 3. 
METHODOLOGY 
Data Source 
The Georgians Organized Against Lupus (GOAL) is a longitudinally designed cohort that 
encompasses a broad cross-section of consented adults with a validated diagnosis of 
SLE (Drenkard et al., 2012).  The overall aim of the GOAL cohort is to ascertain the impact of 
SLE on the lives of Georgians living with the disease to better inform patients, health care 
providers, and policy makers (Drenkard et al., 2014).  The GOAL survey, administered annually 
since 2011, includes questions on socio-economic demographics, work status, access to 
healthcare, lifestyle factors, validated measures of disease outcomes, health status, and mental 
health screening. 
The sample population is taken from the Georgia Lupus Registry (GLR), a CDC-funded 
population-based registry that seeks to estimate the prevalence and incidence of SLE in the 
metropolitan Atlanta, Georgia area.  The GLR was initiated through a partnership between the 
Georgia Department of Public Health (GADPH) and Emory University in which Emory 
investigators were permitted to collect protected health information and clinical data from 
medical records without written patient consent (under the Health Insurance Portability and 
Accountability Act Privacy Rule, 45 Code of Federal Regulations, parts 160 and 164).  
Moreover, the GADPH approved Emory investigators request to recruit GLR SLE patients into 
the GOAL cohort. 
Patients were recruited into the GOAL cohort via mail, phone and in person to complete 
annual self-reported surveys.  Approximately 70% of patients enrolled in the GOAL study were 
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obtained through the GLR.  The remaining enrollees came from lupus clinics at Emory 
University and Grady Memorial Hospital, as well as from community rheumatologists from the 
greater metropolitan Atlanta area. All GOAL participants gave informed consent.  The Emory 
University Institutional Review Board (IRB), Grady Health System Research Oversight 
Committee, and the GADPH Institutional Review Board approved the GOAL study protocol. 
 
Study Design 
Georgia State University IRB provided exempt approval (IRB Number: H15143) for this 
cross-sectional study analysis conducted on the self-reported data collected from Wave 3 GOAL 
survey of SLE patients from the greater metropolitan Atlanta, Georgia area. 
 
Inclusion and Exclusion Criteria 
The sample for this thesis consisted of 652 SLE patients who responded to the survey 
delivered between September 2013 and September 2014. Only respondents that answered all the 
questions for the studied variables were included in the analysis. 
 
Study Variables 
Study variables included self-reported measures of means, standard deviations (SD) and 
proportions (%): 
1. Age at the survey (mean ± SD): self-reported as MM/DD/YYYY but converted to the 
nearest year in age. 
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2. Sex (%): self-reported as male or female. Males were initially coded as one but recoded as 
0. Females were initially coded as two but recoded as 1. 
3. Race (%):In the GOAL survey race includes, American Indian or Alaska Native, Asian, 
Black or African-American, Native Hawaiian/Pacific Islander, or White, coded 1-5, respectively. 
This study was restricted to White, Black or African American, and Other (American Indian or 
Alaska Native, Asian or Native Hawaiian/Pacific Islander), recoded as 0-2 respectively. 
4. Disease duration at the survey (mean ± SD): self-reported as MM/YYYY but converted to 
the nearest year. 
5. Education level (%): In the GOAL survey, respondents self-report their highest grade or 
level of schooling completed coded as 1 -23. In this study, education was categorized as High 
school and below, some college/university, or more than a college/university level, coded 0-2 
respectively; 
6. Marital status (%):  In the GOAL survey, marital status was reported as never married, 
married or cohabited, separated, divorced, widowed, or living with a partner but not married, 
originally coded 0-4 respectively. This study was restricted to married or cohabited, and all other 
(never married, separated, divorced, widowed or living with a partner but not married) recoded as 
0,1 respectively. 
7. Annual household income (%): In the GOAL survey, annual income was reported as  less 
than $10,000; $10,000-$19,000; $20,000-$29,000; $30,000-$39,000; $40,000-$49,000; $50,000-
$59,000; $60,000-$69,000, and more than $70,000; coded as 1-8. This study was restricted to less 
than $29,999; $30,000-$49,999; and more than $50,000; recoded as 0-2. 
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8. Currently employed (%): In the GOAL survey, respondents reported working full-time, 
working part-time, retired, homemaker, student, and unemployed, coded 1-5 and 7 respectively. 
This study was restricted to currently employed and not employed, recoded as 1 and 0 respectively. 
9. Insurance coverage (%): In the GOAL survey, insurance coverage was coded as 0 for no 
and 1 for yes when reporting private insurance, Medicaid, medicare, military health care, Grady 
card, other or no insurance. This study was restricted to uninsured, private, or Medicaid/Medicare, 
recoded as 0-2 respectively. 
10. Visit a psychiatrist in the past 12 months (%): In the GOAL survey, visiting a psychiatrist, 
psychologist or mental health counselor was coded 0=no and 1=yes. 
11. Due to evidence that suggests that disease activity and organ damage are associated with, 
adverse mental health (Jolly et al., 2010) we used the Systemic Lupus Activity Questionnaire 
(SLAQ) and Brief Index of Lupus Damage (BILD) scores to control for disease conditions. SLAQ 
is a validated survey that provides a 3-month range of recall and a score that ranges from 0 to 44 
(Karlson et al., 2003; Yazdany et al. 2008). High scores denote a higher degree of self-reported 
disease activity.  SLAQ was recoded to represent mild (0-10), moderate (11-16) and severe (≥ 17) 
as 0-2, respectively.  BILD is also a patient reported-validated instrument used in the GOAL cohort 
studies (Yazdany et al., 2011).  BILD scores represent no damage (0), mild (1-2), and severe (3 
≤), recoded as 0-2 respectively. 
12. Social Support (%): In the GOAL survey, Emotional support (section XII) is the item used 
in this analysis: “How often do you get the social and emotional support you need? (This is support 
from any source).”  Responses were divided into five categories (always, usually, sometimes, 
rarely, never).  This study restricted the categories to patients who report enough emotional support 
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(always, usually, sometimes) and patients who report not having enough emotional support (rarely, 
never), coded as 0 and 1 respectively.   
13. Physician Social Support: In the GOAL survey, Mental Health Screening (section XIII) is the 
item from the Mental Health screening section used in this analysis: “Over the past 12 months, has 
your Primary Care Doctor (Internal Medicine, Family Practice, General Practitioner, 
Gynecologist, etc.), Rheumatologist (lupus doctor) or another doctor ) asked if you have been 
feeling down, depressed or hopeless?”  Responses were coded as 0 for no and 1 for responses 
answered in the affirmative. 
14. Depression (%): The Patient Health Questionnaire (PHQ-9) is a self-reported measure of 
depression module.  It is based on the nine criteria outlined in the Diagnostic and Statistical Manual 
of Mental Disorders 4th Edition (DSM-IV) for the diagnosis of clinical depression.  The PHQ-9 
has been determined to be a reliable screening measure for depression (Moldovan et al., 2011).  It 
can be evaluated either by a diagnostic algorithm to identify major depressive disorder (MDD) or 
as a continuous measure with scores ranging from 0 to 27 with defined cut points indicating severe 
levels of depression: 5 (mild), 10 (moderate), 15 (moderately severe),  and 20 (severe) (Kroenke, 
Spitzer, Williams, & Lowe, 2010).  Similar to previous publication (Kroenke, Spitzer, & Williams, 
2001), the PHQ9-Depression scores were restricted to minimally/moderately depressed (score 
range of 0-9) or moderate/severe depression (score range of 10-27), coded as 0 and 1 respectively. 
15. Mental Health Well-being (%):  The Short Form family of health status instrument is a 
widely used measure and a robust, validated health status assessment tool (Garratt, Schmidt, 
Mackintosh, & Fitzpatrick, 2002). The GOAL survey measured mental health well-being using 
the self-administered SF-12. The self-administered SF-12 is derived from the 36 item short form 
(SF-36), which has two principal measures (physical component summary and mental health 
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summary) and 8 subscale domains (physical functioning, role physical, bodily pain, general health, 
vitality, social functioning, role emotional and mental health). The SF-12, however, can only 
provide the physical component summary and mental component scores (MCS-SF12), with higher 
scores indicating a better healthy well-being (Tamayo, Fischer-Betz, Beer, Winkler-Rohlfing, & 
Schneider, 2010). MCS-SF12 scores were coded as 0 for being below the U.S. population average 
score of 50 and 1 for being above the U.S. population average score of 50. 
 
Statistical Analysis 
Subjects with missing data on the main variables were excluded from this analysis. Preliminary 
test for normality were conducted before statistical analysis was done using SPSS (version 22) 
software. Descriptive statistics, including means with standard deviations (SD) for continuous 
variables were used to compare continuous variables across studied dependent variables. Kendall's 
Tau-b was used to determine the relationship between the measures of social support, PHQ9 
depression scores and SF-12 scores. Independent T-tests were conducted to compare respondents 
who received social support from a physician to those who did not receive social support from a 
physician using the mental component scores and the PHQ9 depression scores. Binary logistic 
regression analysis was performed to assess the likelihood that respondents would be categorized 
as having a below average mental component score or above average. Both, univariate and 
multivariate logistic regression analyses were conducted to determine associations between 
selected characteristic and main independent variables with the mental component score and PHQ9 
depression score, individually and together. Ninety-five percent confidence intervals were used to 
determine statistical significance. 
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Chapter 4. 
Results 
A total of 652 SLE respondents participated in the GOAL study, which was conducted in 
the period between late September 2013 and early September 2014. As shown in Table 1, 93% of 
eligible participants were women, 78.4% African American, 19.5% white, and 2.1% other races. 
The mean ± SD for age at survey and disease duration at survey was 48.9 ± 13.1 years and 16.0 ± 
9.7 years, respectively. Although 47% had at least some college education, 65% were 
unemployed, and 11.7% were uninsured. Among those insured, 35.6% had private insurance and 
52.8% had Medicaid or Medicare. 44.9% of SLE patients have severe disease activity and 39.9% 
have severe organ damage. The mean ± SD for the mental component score PHQ9 depression 
score was 44.50 ± 11.41 and 7.98 ± 6.23, respectively. The majority of the SLE patients (58.1%) 
reported always having enough emotional or social support from any source while 41.9% report 
not having enough emotional or social support. Majority of the SLE patients across all variables 
did not have a physician serve as a source of social support nor visited a psychiatrist over the 
past 12 months. Majority (62.4%) of the patients who reported having enough emotional and 
social support did not receive any from physicians in the past 12 months. 
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Table 1. Socio-demographics of Systemic Lupus Erythematosus patients in the GOAL 
study 
 
Characteristic 
GOAL 
Cohort 
(N=652) 
Has a physician served as a role of 
social support? 
No (N=489)       Yes (N=163) 
Age at survey, years (mean ± SD) 48.9 ± 13.1 48.7 ± 13.4 49.3 ± 11.9 
Disease Duration, years (mean ± SD) 16.0 ± 9.7 16.3 ± 9.6 15.4 ± 9.8 
Gender 
Male 
Female 
 
43 (6.6) 
609 (93.4) 
 
29 (5.9) 
460 (94.1 
 
14 (8.6) 
149 (91.4) 
Race 
White 
African American 
Other 
 
127 (19.5) 
511 (78.4) 
14 (2.1) 
 
101 (20.7) 
377 (77.1) 
11 (2.2) 
 
26 (16.0) 
134 (82.2) 
3 (1.8) 
Education Level 
≤ High School 
Some College 
≥ College/University 
 
199 (31.1) 
303 (47.3) 
138 (21.2) 
 
142 (29.6) 
224 (46.7) 
114 (23.8) 
 
57 (35.6) 
79 (49.4) 
24 (15.0) 
Marital Status 
All other  
Married/Cohabitated 
383 (58.7) 
269 (41.3) 
 
279 (57.1)  
210 (42.9) 
 
104 (63.8) 
59 (36.2) 
Annual Household income 
≤ $29,999 
$30,000-$49,999 
≥ $50,000 
 
315 (52.9) 
83 (13.9) 
197 (33.1) 
 
230 (51.6) 
57 (12.8) 
159 (35.7) 
 
85 (57.0) 
26 (17.4) 
38 (23.3) 
Currently employed 
No 
Yes 
 
424 (65.0) 
228 (35.0) 
 
191 (39.1) 
298 (60.9) 
 
126 (77.3) 
37 (22.7) 
Insurance Type 
Uninsured 
Private 
Medicare/Medicaid 
 
76 (11.7) 
232 (35.6) 
344 (52.8) 
 
58 (11.9) 
192 (39.3) 
239 (48.9) 
 
18 (11.0) 
40 (24.5) 
105 (64.4) 
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Disease Activity Score 
Mild (0-10) 
Moderate (11-16) 
Severe (≥ 17) 
 
194 (29.8) 
165 (25.3) 
293 (44.9) 
 
164 (33.5) 
134 (27.4) 
191 (39.1) 
 
30 (18.4) 
31 (19.0) 
102 (62.6) 
Organ Damage Score 
No Damage 
Mild (1-2) 
Severe (≥3) 
 
147 (22.5) 
245 (37.6) 
260 (39.9) 
 
129 (26.4) 
179 (36.6) 
181 (37.0) 
 
18 (11.0) 
66 (40.5) 
79 (48.5) 
Visit a Psychiatrist in past 12 months? 
No 
Yes 
546 (86.3) 
87 (13.7) 
442 (93.1) 
33 (6.9) 
104 (65.8) 
54 (34.2) 
Receiving enough emotional support 
Not enough 
Enough 
272 (41.9) 
377 (58.1) 
183 (37.6) 
304 (62.4) 
89 (54.9) 
73 (45.1) 
Mental Component Score (mean ± SD) 44.50 ± 11.41 46.7 ± 10.6 38.0 ± 11.2 
Depression Screener Score (mean ± SD) 7.98 ± 6.23 6.89 ± 5.8 11.2 ± 6.4 
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Tables 2 and 3 show results from the independent-samples t-test that were conducted to 
compare the mental component scores and the PHQ9 depression scores for the main independent 
variables. There was a significant difference in scores for both test variables. The mental 
component score for those categorized as having enough emotional or social support was greater 
(M=48.1, SD= 10.4) than those who were categorized as not having enough emotional or social 
support (M=39.6, SD=10.9); t (507)=8.89, p <.001. The PHQ9 depression score was lower for 
those who were categorized as having enough emotional or social support (M=6.2, SD=5.3) than 
those who did not have enough emotional or social support (M=10.5, SD=6.5); t(621)= -9.76, p< 
0.001.The mental component score for those categorized as having social support from a 
physician was lower (M=38.0, SD= 11.2) than those who were not categorized as having social 
support from a physician (M=46.7, SD=10.6); t(624)=8.73, p <.001. The PHQ9 depression score 
was higher for those who were categorized as having social support from a physician (M=11.2, 
SD=6.4) than those who did not have social support from a physician (M=6.9, SD=5.8); t (254) = 
-7.67, p< 0.001.  
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Table 2. Comparison of Mental Component and Depression Screener Scores by Physician 
Social Support Using the Student’s t-Test 
 
Variable 
Has a physician served as a role of social 
support? 
No                  Yes  t df 
Mental Component Score 46.7 ± 10.6 38.0 ± 11.2 8.73* 624 
PHQ9 Depression Score 6.89 ± 5.8 11.2 ± 6.4 -7.67* 254 
* p < .001 
 
 
Table 3. Comparison of Mental Component and Depression Screener Scores by Emotional 
Support Using the Student’s t-Test 
 
Variable 
Does patient have enough emotional or social 
support? 
Not Enough                    Enough t df 
Mental Component Score 39.6 ± 10.9 48.1 ± 10.4 8.89* 507 
PHQ9 Depression Score 10.5 ± 6.5 6.2 ± 5.3 -9.76* 621 
* p < .001 
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Kendall’s tau b correlation coefficient was used to investigate the relationship amongst 
the independent variables (age at survey; sex; race; disease duration at survey; education level; 
marital status; annual household income; employment status; insurance coverage; disease 
activity; organ damage; and status on visiting a psychiatrist in the past 12 months), Table 4. 
There was a weak, positive correlation for disease activity (tau = .19, p <.01), disease organ 
damage (tau = .14, p < .01), and type of insurance (tau = .11, p < .01) with social support from a 
physician. There was a moderate, negative correlation between disease activity score and 
emotional or social support, tau=-.20, p <.01. There was a weak, negative correlation for 
education (tau = -.08, p <.05) and current employment status (tau = -.15, p <.01) with social 
support from a physician. There was a strong, positive correlation between psychiatrist visited in 
past 12 months and social support from a physician, tau=.34, p <.01. Kendall’s tau b correlation 
coefficient was used to investigate the relationship amongst the independent variables and the 
dependent variables MCS-SF12 score and PHQ9 score, Table 5. There was a moderate, positive 
correlation between emotional or social support and MCS-SF12 scores (tau = .29, p < .01), and a 
strong, negative correlation for emotional or social support and PHQ9 depression scores (tau = 
-.30, p< .01). There were moderate correlations for MCS-SF12 scores (tau = -.25, p <.01 ), and 
PHQ9 scores (tau = .29, p< .01) with social support from a physician. Disease activity had a 
strong, negative correlation with MCS-SF12 scores (tau = -.426, p< .01) and a strong, positive 
correlation with PHQ9 depression scores (tau = .49, p <.01). 
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Table 4. Correlation Between Physicians’ Emotional or Social Support and Social support  
 Emotional or social 
Support 
Physician social 
support 
Disease Activity Score -.204** .189** 
Disease Organ Damage Score -.055 .138** 
Age at Survey .034 .019 
Disease Duration .016 -.040 
Sex -.020 -.046 
Education .079* -.083* 
What is your current relationship 
status? 
.076 -.059 
Type of Insurance .002 .113** 
Annual income .073 -.067 
Currently employed -.002 -.149** 
Visit a psychiatrist in past 12 
months? 
-.081* .342** 
Values are Kendall’s Tau b Coefficients 
**. Correlation is significant at P<0.01 level (2-tailed). 
*. Correlation is significant at P< 0.05 level (2-tailed). 
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Table 5. Correlation Between Mental Component Score and PHQ9 Depression Score 
 MCS-SF12 Score PHQ9 Depression Score 
Emotional or social Support 
 
.294** -.298** 
Physician social support 
 
-.248** .293** 
Age at Survey .035 -.016 
Disease Duration .051 -.001 
Sex -.004 .106** 
Education .057 -.070 
Marital Status -.003 -.006 
Type of Insurance -.055 .055 
Annual Income .087* -.153** 
Currently employed .152** -.191** 
Visited a psychiatrist in the past 12 
months? 
-.213** .224** 
Disease Activity Score -.426** .485** 
Disease Organ Damage Score -.097* .170** 
Values are Kendall’s Tau b Correlation Coefficients 
**Correlation is significant at P<0.01 level (2-tailed).  
*Correlation is significant at P<0.05 level (2-tailed). 
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Three types of models were completed for the mental component scores and PHQ9 
depression scores: one for all characteristic variables separately, all characteristic variables with 
one of the main independent variables entered into the model, and all variables entered into the 
model altogether.  Table 6 and 7 shows the association of the individual variables (univariate 
regression) and the full model (multivariate regression) analyses with mental component scores.  
A few statistically significant findings were found in both the univariate and multivariate 
analysis for mental component scores; patients who have social support from a physician have an 
unadjusted odds ratio of .24 (95% CI 0.15 – 0.38, p < .001) and an adjusted odds ratio of .34 
(95% CI .19 - .60, p < .001).  For patients reporting enough emotional support, there was an 
unadjusted and adjusted odds ratio of 3.87 (95% CI 2.66 – 5.62, p < .001) and 3.27 (95 CI 2.07 – 
5.14, p < .001), respectively.  Disease activity and psychiatrist visits in the past 12 months were 
also statistically significantly associated with decreased mental component scores in the 
univariate and both multivariate regressions.  Patients with moderate or severe disease activity 
scores had an unadjusted odds ratio of 0.29 (95% CI 0.19 – 0.45, p <.001) and 0.09 (95% CI 0.06 
– 0.14, p < .001), respectively. Patients with moderate disease activity scores had an adjusted 
odds ratio for the model containing physician support, 0.28 (95% CI 0.15 – 0.44, p <.001) and 
0.32 (95% CI 0.19 – 0.55, p < .001) for the model containing emotional or social support. Severe 
disease activity had an unadjusted 0.09 (95% CI 0.05 – 0.16, p < .001) and an adjusted odds ratio 
for the model containing social support from a physician of 0.10 (95% CI 0.06 – 0.18, p < .001). 
Patients who visited a psychiatrist in the past 12 months had an unadjusted and adjusted odds 
ratio (model containing physician support model and emotional or social support model) of 0.16 
(95% CI 0.08 – 0.35, p < .001), 0.36 (95% CI 0.16 – 0.83, p < .05), and 0.25 (95% CI 0.11 – 
0.57, p < .01). Patients who received social support from a physician, had greater disease activity 
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or visited a psychiatrist within the year are more likely to have a below U.S. normal average 
mental component score than those without social support from a physician, no disease activity 
or no psychiatrist visit. Patients who reported having enough emotional or social support had 
greater odds of having an above average mental component score than those who report not 
having enough support.  
Annual income and employment status were significantly associated with increased mental 
component and PHQ9 depression scores in the univariate regression analyses but not in the 
multivariate regressions. Organ damage was significantly associated with decreased mental 
component and PHQ9 depression scores in the univariate regression analyses but not in the 
multivariate regressions. Having an annual income over $50,000 (OR =1.55, 95% CI 1.06 – 2.26, 
p < .05) or being employed (OR= 1.93, 95% CI 1.37 – 2.71, p < .001) yielded a greater odds of 
having an above average mental component score than having an annual income below $30,000 
or being unemployed, respectively. Greater organ damage was associated with a greater odds 
(OR= 0.56, 95% CI 0.36 – 0.86, p < .01) of having a below average mental component score 
than those with no organ damage. 
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Table 6. Results of the Univariate and Multivariate Logistic Regression Analyses of the 
Association of Physician Social Support with Other Characteristics Using the Mental 
Component Score  
 Univariate Regression Multivariate Regression 
 OR 95% CI p-value OR 95% CI p-value 
Physician Social Support  
No 
Yes 
 
 
.237 
 
Ref 
.147 - .383 
 
 
≤.001*
** 
 
 
.339 
 
Ref 
.191-.601 
 
 
≤.001*** 
Age 1.00 .995-1.02 .257 1.007 .988-1.027 .467 
Sex 
Male 
Female 
 
 
.966 
 
Ref 
.491-1.898 
 
 
.919 
 
 
1.128 
 
Ref 
.505-2.522 
 
 
.708 
Race 
White 
Black 
Other 
 
 
1.046 
1.446 
 
Ref 
.690-1.587 
.471-4.443 
 
 
.831 
.519 
 
 
1.612 
1.099 
 
Ref 
.928-2.798 
.257-4.696 
 
 
.090 
.899 
Disease Duration 1.014 .997-1.032 .097 1.009 .985-1.034 .456 
Education Level 
≤ High School 
Some College 
≥ College/University  
 
 
1.005 
1.462 
 
Ref 
.681-1.484 
.925-2.310 
 
 
.979 
.104 
 
 
.840 
1.113 
 
Ref 
.502-1.406 
.587-2.110 
 
 
.508 
.744 
Marital Status 
All other  
Married/Cohabitated 
 
 
.989 
 
Ref 
.709-1.380 
 
 
.949 
 
 
1.008 
 
Ref 
.631-1.611 
 
 
.972 
Annual Household income 
≤ $29,999 
$30,000-$49,999 
≥ $50,000 
 
 
1.036 
1.546 
 
Ref 
.612-1.754 
1.060-
2.255 
 
 
.895 
.024* 
 
 
1.170 
.887 
 
Ref 
.588-2.325 
.446-1.766 
 
 
.655 
.734 
Currently employed       
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No 
Yes 
 
1.927 
Ref 
1.371-
2.708 
 
≤.001*
** 
 
1.454 
Ref 
.839-2.521 
 
.182 
Insurance Type 
Uninsured 
Private 
Medicare/Medicaid 
 
 
1.444 
.974 
 
Ref 
.822-2.536 
.563-1.685 
 
 
.202 
.925 
 
 
.848 
1.319 
 
Ref 
.389-1.851 
.625-2.783 
 
 
.679 
.467 
Disease Activity Score 
Mild (0-10) 
Moderate (11-16) 
Severe (≥ 17) 
 
 
.288 
.089 
 
Ref 
.185-.450 
.057-.139 
 
 
≤.001*
** 
≤.001*
** 
 
 
.281 
.091 
 
Ref 
.154-.443 
.052-.158 
 
 
≤.001*** 
≤.001*** 
Organ Damage Score 
No Damage 
Mild (1-2) 
Severe (≥3) 
 
 
.689 
.558 
 
Ref 
.449-1.056 
.362-.858 
 
 
.087 
.008** 
 
 
1.265 
1.159 
 
Ref 
.731-2.191 
.628-2.139 
 
 
.401 
.637 
Visit a Psychiatrist in past 
12 months? 
No 
Yes 
 
 
 
.164 
 
 
Ref 
.078-.348 
 
 
 
≤.001*
** 
 
 
 
.361 
 
 
Ref 
.156-.834 
 
 
 
.017* 
*p < .05, **p < .01, ***p < .001 
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Table 7. Results of the Univariate and Multivariate Logistic Regression Analyses of the 
Association of Emotional Support with Other Characteristics Using the Mental Component 
Score 
 Univariate Regression Multivariate Regression 
 OR 95% CI p-value OR 95% CI p-value 
Emotional Social Support 
Not enough 
Enough 
 
 
 
3.87 
 
Ref 
2.66-5.62 
 
 
≤.001 
 
 
3.27 
 
Ref 
2.07-5.14 
 
 
≤.001 
Age 1.00 1.00-1.02 .26 1.01 .99-1.03 .59 
Sex 
Male 
Female 
 
 
.97 
 
Ref 
.49-1.90 
 
 
.92 
 
 
1.12 
 
Ref 
.49-2.57 
 
 
.78 
Race 
White 
Black 
Other 
 
 
1.05 
1.45 
 
Ref 
.69-1.59 
.47-4.44 
 
 
.83 
.52 
 
 
1.58 
.93 
 
Ref 
.90-2.77 
.21-4.08 
 
 
.12 
.93 
Disease Duration 1.01 1.00-1.03 .10 1.01 .99-1.04 .39 
Education Level 
≤ High School 
Some College 
≥ College/University 
 
 
1.01 
1.46 
 
Ref 
.68-1.48 
.93-2.31 
 
 
.98 
.10 
 
 
.86 
1.03 
 
Ref 
.51-1.44 
.54-1.96 
 
 
.56 
.99 
Marital Status 
All other 
Married/Cohabitated 
 
 
.99 
 
Ref 
.71-1.38 
 
 
.95 
 
 
.91 
 
Ref 
.57-1.46 
 
 
.70 
Annual Household income 
≤ $29,999 
$30,000-$49,999 
≥ $50,000 
 
 
1.04 
1.55 
 
Ref 
.61-1.75 
1.06-2.26 
 
 
.90 
.02* 
 
 
1.15 
.91 
 
Ref 
.58-2.29 
.45-1.82 
 
 
.70 
.78 
Currently employed 
No 
Yes 
 
 
1.93 
 
Ref 
1.37-2.71 
 
 
≤.001 
 
 
1.73 
 
Ref 
.99-3.04 
 
 
.06 
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Insurance Type 
Uninsured 
Private 
Medicare/Medicaid 
 
 
1.44 
.97 
 
Ref 
.82-2.54 
.56-1.69 
 
 
.20 
.93 
 
 
.79 
1.22 
 
Ref 
.36-1.77 
.57-2.59 
 
 
.57 
.61 
Disease Activity Score 
Mild (0-10) 
Moderate (11-16) 
Severe (≥ 17) 
 
 
.29 
.09 
 
Ref 
.19-.45 
.06-.14 
 
 
≤.001 
≤.001 
 
 
.32 
.10 
 
Ref 
.19-.55 
.06-.18 
 
 
≤.001 
≤.001 
Organ Damage Score 
No Damage 
Mild (1-2) 
Severe (≥3) 
 
 
.69 
.56 
 
Ref 
.45-1.06 
.36-.86 
 
 
.09 
.008** 
 
 
1.17 
1.21 
 
Ref 
.672-
2.046 
.652-
2.245 
 
 
.58 
.55 
Visit a Psychiatrist in past 
12 months? 
No 
Yes 
 
 
 
.16 
 
 
Ref 
.08-.35 
 
 
 
≤.001*** 
 
 
 
.25 
 
 
Ref 
.11-.57 
 
 
 
.001** 
*p < .05, **p < .01, ***p < .001 
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Table 8 and Table 9 show the association between selected independent variables with the 
PHQ9 depression scores.  Social support from a physician was significantly associated with 
depression in both univariate and multivariate analyses.  Having social support from a physician 
yielded 3.93 unadjusted greater odds (95% CI 2.72 – 5.70, p < .001) of being 
moderately/severely depressed than those without physician support.  Having social support from 
a physician yielded 3.67 adjusted greater odds (95% CI 2.21 – 6.11, p < .001) of being 
moderately/severely depressed than those without physician support.  Having enough emotional 
support was also found to be significantly associated with depression.  Patients who reported 
having enough emotional or social support had approximately 70% less odds (unadjusted OR = 
0.28, 95% CI 0.20 – 0.39, p < .001; adjusted OR= 0.32, 95% CI 0.21 – 0.50, p < .001) of being 
moderately depressed than those who did not have enough emotional or social support.  Disease 
activity and psychiatrist visits in the past 12 months were also statistically significantly 
associated with PHQ9 depression scores in the univariate and both multivariate regressions.  
Patients with moderate or severe disease activity scores had an unadjusted odds ratio of 7.02 
(95% CI 3.30– 14.94, p <.001) and 32.28 (95% CI 15.88– 65.59, p < .001).  Patients with 
moderate disease activity scores had an adjusted odds ratio of 7.71 (95% CI 3.13 – 19.01, p 
<.001) and 5.87 (95% CI 2.42 – 14.29, p < .001) for the model containing physician support and 
emotional or social support, respectively; severe disease activity had an adjusted odds ratio of 
32.39 (95% CI 13.54 – 77.50, p < .001) and 25.72 (95% CI 11.00 – 60.32, p < .001) for the 
model containing physician support and emotional or social support, respectively.  Patients who 
visited a psychiatrist in the past 12 months had an unadjusted and adjusted odds ratio (model 
containing physician support model and emotional or social support model) of 0.16 (95% CI 0.08 
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– 0.35, p < .001), 0.36 (95% CI 0.16 – 0.83, p < .05), and 0.25 (95% CI 0.11 – 0.57, p < .01), 
respectively. 
In the univariate analyses, sex, education, annual income, employment status and organ 
damage were significantly associated with depression. However, in the full model these variables 
were no longer significant. Female SLE patients (OR = 2.97, 95% CI 1.30 – 6.79, p < .05), 
having a mild organ damage (OR = 1.71, 95% CI 1.07 – 2.73, p <.05) or having severe organ 
damage (OR = 2.78, 95% CI 1.76 – 4.40, p < .001) were associated with increased odds of 
moderate/severe depression compared to males and subjects with no organ damage, respectively. 
Having a college/university (OR = 0.62, 95% CI 0.39 - 0.996, p < .05), an annual income that is 
greater than $50,000 (OR = 0.44, 95% CI 0.30 – 0.66, p < .001), or being employed (OR = 0.41, 
95% CI 0.28 – 0.59, p < .001) were associated with decreased odds of moderate/severe 
depression compared to subjects with a high school education or lower  annual income less than 
$30,000, or unemployed, respectively.  
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Table 8. Results of the Univariate and Multivariate Logistic Regression Analyses of the 
Association of Physician Social Support with Other Characteristics Using the PHQ9-
Depression Score 
 Univariate Regression Multivariate Regression 
 OR 95% CI p-value OR 95% CI p-value 
Physician Support 
No 
Yes 
 
 
 
3.90 
 
Ref 
2.72 – 5.70 
 
 
≤.001 
 
 
3.67 
 
Ref 
2.21- 6.11 
 
 
≤.001 
Age 1.00 .99-1.01 .72 .99 .97-1.01 .20 
Sex 
Male 
Female 
 
 
2.97 
 
Ref 
1.30-6.79 
 
 
.010** 
 
 
3.26 
 
Ref 
1.17- 9.06 
 
 
.02 
Race 
White 
Black 
Other 
 
 
1.01 
.50 
 
Ref 
.67-1.51 
.13- 1.87 
 
 
.97 
.30 
 
 
.62 
.67 
 
Ref 
.34- 1.13 
.10- 4.25 
 
 
.12 
.67 
Disease Duration 1.00 .98-1.01 .10 1.01 .98- 1.03 .67 
Education Level 
≤ High School 
Some College 
≥ College/University 
 
 
.90 
.62 
 
Ref 
.62- 1.31 
.391-1.00 
 
 
.59 
.05* 
 
 
1.09 
.90 
 
Ref 
.65- 1.83 
.45 – 1.79 
 
 
.73 
.76 
Marital Status 
All other 
Married/Cohabitated 
 
 
.98 
 
Ref 
.70- 1.35 
 
 
.88 
 
 
1.22 
 
Ref 
.74- 2.00 
 
 
.43 
Annual Household income 
≤ $29,999 
$30,000-$49,999 
≥ $50,000 
 
 
.91 
.44 
 
Ref 
.55- 1.49 
.30- .66 
 
 
.91 
≤.001 
 
 
.64 
.63 
 
Ref 
.33- 1.27 
.30- 1.32 
 
 
.21 
.22 
Currently employed 
No 
Yes 
 
 
.41 
 
Ref 
.28- .59 
 
 
≤.001 
 
 
.74 
 
Ref 
.41- 1.35 
 
 
.33 
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Insurance Type 
Uninsured 
Private 
Medicare/Medicaid 
 
 
.57 
.93 
 
Ref 
.33- .97 
.56- 1.54 
 
 
.04 
.77 
 
 
1.60 
.80 
 
Ref 
.71- 3.59 
.39- 1.64 
 
 
.25 
.53 
Disease Activity Score 
Mild (0-10) 
Moderate (11-16) 
Severe (≥ 17) 
 
 
7.02 
32.28 
 
Ref 
3.30- 14.94 
15.88- 
65.59 
 
 
≤.001 
≤.001 
 
 
7.71 
32.39 
 
Ref 
3.13- 
19.01 
13.54- 
77.50 
 
 
≤.001 
≤.001 
Organ Damage Score 
No Damage 
Mild (1-2) 
Severe (≥3) 
 
 
1.71 
2.78 
 
Ref 
1.07- 2.73 
1.76-4.40 
 
 
.026* 
≤.001** 
 
 
.83 
1.27 
 
Ref 
.44- 1.57 
.65- 2.47 
 
 
.58 
.48 
Visit a Psychiatrist in past 
12 months? 
No 
Yes 
 
 
 
3.65 
 
 
Ref 
.08-.35 
 
 
 
≤.001*** 
 
 
 
2.04 
 
 
Ref 
1.08- 3.86 
 
 
 
.03* 
*p < .05, **p < .01, ***p < .001 
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Table 9. Results of the Univariate and Multivariate Logistic Regression Analyses of the 
Association of Emotional support with other characteristics Using the PHQ9-Depression 
Score 
 Univariate Regression Multivariate Regression 
 OR 95% CI p-value OR 95% CI p-value 
Emotional Social Support 
Not enough 
Enough 
 
 
 
.28 
 
Ref 
.20 - .39 
 
 
≤.001 
 
 
.32 
 
Ref 
.21- .50 
 
 
≤.001 
Age 1.00 .99-1.01 .72 .99 .97-1.01 .35 
Sex 
Male 
Female 
 
 
2.97 
 
Ref 
1.30-6.79 
 
 
.010** 
 
 
3.48 
 
Ref 
1.20 – 10.12 
 
 
.02 
Race 
White 
Black 
Other 
 
 
1.01 
.50 
 
Ref 
.67-1.51 
.13- 1.87 
 
 
.97 
.30 
 
 
.71 
.85 
 
Ref 
.39- 1.29 
.14- 5.31 
 
 
.26 
.86 
Disease Duration 1.00 .98-1.01 .10 1.00 .98- 1.03 .89 
Education Level 
≤ High School 
Some College 
≥ College/University 
 
 
.90 
.62 
 
Ref 
.62- 1.31 
.391-1.00 
 
 
.59 
.048* 
 
 
1.09 
.90 
 
Ref 
.65-1.83 
.45-1.79 
 
 
.74 
.90 
Marital Status 
All other 
Married/Cohabitated 
 
 
.98 
 
Ref 
.70- 1.35 
 
 
.88 
 
 
1.30 
 
Ref 
.79- 2.13 
 
 
.30 
Annual Household income 
≤ $29,999 
$30,000-$49,999 
≥ $50,000 
 
 
.91 
.44 
 
Ref 
.55- 1.49 
.295- .66 
 
 
.91 
≤.001 
 
 
.72 
.65 
 
Ref 
.37-1.43 
.311-1.34 
 
 
.35 
.24 
Currently employed 
No 
Yes 
 
 
.41 
 
Ref 
.28- .59 
 
 
≤.001 
 
 
.63 
 
Ref 
.34-1.15 
 
 
.13 
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Insurance Type 
Uninsured 
Private 
Medicare/Medicaid 
 
 
.57 
.93 
 
Ref 
.33- .97 
.56- 1.54 
 
 
.04 
.77 
 
 
1.67 
.91 
 
Ref 
.74- 3.77 
.44- 1.90 
 
 
.22 
.81 
Disease Activity Score 
Mild (0-10) 
Moderate (11-16) 
Severe (≥ 17) 
 
 
7.02 
32.28 
 
Ref 
3.30- 14.94 
15.88- 
65.59 
 
 
≤.001*** 
≤.001*** 
 
 
5.87 
25.72 
 
Ref 
2.42- 14.29 
10.97- 60.32 
 
 
≤.001 
≤.001 
Organ Damage Score 
No Damage 
Mild (1-2) 
Severe (≥3) 
 
 
1.71 
2.78 
 
Ref 
1.07- 2.73 
1.76-4.40 
 
 
.03* 
≤.001** 
 
 
.92 
1.35 
 
Ref 
.49- 1.72 
.70- 2.62 
 
 
.79 
.38 
Visit a Psychiatrist in past 
12 months? 
No 
Yes 
 
 
 
3.65 
 
 
Ref 
.08-.35 
 
 
 
≤.001 
 
 
 
2.88 
 
 
Ref 
1.53- 5.39 
 
 
 
.001** 
*p < .05, **p < .01, ***p < .001 
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Table 10 shows the results for the full multivariate regression analysis using mental 
component score and PHQ9 depression scores as dependent variables.  In both models, only 
physician social support, emotional support, disease activity, and psychiatrist visits were 
significantly associated with increased or decreased odds of having an above US average mental 
health score and being depressed. Having social support from a physician was associated with a 
64% decreased odds (OR= 0.36, 95% CI .20 - .660, p <.01) of having an above average US 
mental component score compared to subjects without social support from a physician. Having 
social support from a physician was also associated with a 3.43 times greater odds (95% CI 2.02 
– 5.82, p <.001) of being moderately/severely depressed compared to patients without social 
support from a physician.  Having enough emotional or social support was associated with 3.13 
increased odds (95 % CI 1.97 – 4.96, p < .001) and 64% decreased odds (OR= 0.36, 95% CI 0.23 
– 0.56, p < .001) of having an above average mental component score and being 
minimally/mildly depressed, respectively. Moderate and severe disease activity yielded odds 
ratios of 0.31 (95% CI 0.18 – 0.53, p < .001) and 0.11 (95% CI 0.06 – 0.19, p < .001), 
respectively, for the mental component score model. In the PHQ9 depression score model, 
moderate and severe disease activity yielded odds ratios of 6.39 (95% CI 2.57 – 15.90, p < .001) 
and 27.70 (95% CI 11.51 – 66.66, p < .001), respectively. Psychiatrist visits yielded adjusted 
odds ratios of 0.35 (95% CI 0.15 – 0.82, p < .05) and 2.02 (95%CI 1.05 – 3.89, p < .05) for the 
models containing mental component scores and PHQ9 depression scores, respectively. For the 
PHQ9 depression model, gender was found to be statistically significant; adjusted for all the 
other variables in the model, females had a 3.52 (95% CI 1.19 – 10.39, p < .05) greater odds of 
being moderately/severely depressed than their male counterparts. 
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Table 10. Results of the Multivariate Logistic Regression Analyses of the Associations of  
Mental Component Score with the PHQ9-Depression Score  
 MCS-SF12 Score PHQ9-Depression Score 
 OR OR 95% CI p-value OR OR 95% CI p-value 
Emotional support 
Not enough Support 
Enough Support 
 
 
3.13 
 
Ref 
1.97 – 4.96 
 
 
≤.001 
 
 
.36 
 
Ref 
.23 - .56 
 
 
≤.001 
Physician Social Support 
No 
Yes 
 
 
.36 
 
Ref 
.20- .66 
 
 
.001** 
 
 
3.43 
 
Ref 
2.02 – 5.82 
 
 
≤.001 
Age 1.01 .99 – 1.03 .57 .99 .97 – 1.01 .37 
Sex 
Male 
Female 
 
 
1.06 
 
Ref 
.46 – 2.40 
 
 
.90 
 
 
3.52 
 
Ref 
1.19 – 10.39 
 
 
.02* 
Race 
White 
Black 
Other 
 
 
1.67 
.08 
 
Ref 
.94 – 2.94 
.23-4.31 
 
 
.08 
1.00 
 
 
.64 
.87 
 
Ref 
.35 – 1.18 
.14 – 5.65 
 
 
.16 
.89 
Disease Duration 1.01 .99 – 1.04 .41 1.01 .98 – 1.03 .73 
Education Level 
≤ High School 
Some College 
≥ College/University 
 
 
.84 
.95 
 
Ref 
.49 – 1.42 
.49 – 1.83 
 
 
.51 
.87 
 
 
1.13 
1.03 
 
Ref 
.66 – 1.92 
.50 – 2.09 
 
 
.66 
.94 
Marital Status 
All other 
Married/Cohabitated 
 
 
.92 
 
Ref 
.57 – 1.48 
 
 
.73 
 
 
1.39 
 
Ref 
.83 – 2.32 
 
 
.21 
Annual Household income 
≤ $29,999 
$30,000-$49,999 
≥ $50,000 
 
 
1.30 
1.00 
 
Ref 
.64 – 2.63 
.49 – 2.03 
 
 
.47 
1.00 
 
 
.603 
.58 
 
Ref 
.30 – 1.22 
.27 – 1.25 
 
 
.16 
.17 
Currently employed       
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No 
Yes 
 
1.70 
Ref 
.96 – 3.00 
 
.07 
 
.67 
Ref 
.36 – 1.24 
 
.20 
Insurance Type 
Uninsured 
Private 
Medicare/Medicaid 
 
 
.75 
1.25 
 
Ref 
.33 – 1.68 
.58 – 2.69 
 
 
.48 
.57 
 
 
1.73 
.89 
 
Ref 
.75– 3.98 
.42 – 1.88 
 
 
.20 
.75 
Disease Activity Score 
Mild (0-10) 
Moderate (11-16) 
Severe (≥ 17) 
 
 
.31 
.11 
 
Ref 
.18 - .53 
.06 - .19 
 
 
≤.001 
≤.001 
 
 
6.39 
27.70 
 
Ref 
2.57 – 15.90 
11.51 – 66.66 
 
 
≤.001 
≤.001 
Organ Damage Score 
No Damage 
Mild (1-2) 
Severe (≥3) 
 
 
1.28 
1.25 
 
Ref 
.73 – 2.24 
.67 – 2.34 
 
 
.40 
.48 
 
 
.79 
1.21 
 
Ref 
.41 – 1.50 
.61 – 2.39 
 
 
.46 
.58 
Psych visit in past 12 months? 
No 
Yes 
 
 
.35 
 
Ref 
.15 - .82 
 
 
.02* 
 
 
2.02 
 
Ref 
1.05 – 3.89 
 
 
.03* 
*p < .05, **p < .01, ***p < .001 
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Chapter 5. 
Discussion 
Discussion of Research Questions 
The purpose of this study was to examine the association between social support and the 
mental health well-being of SLE patients. Study findings suggest that perceived emotional 
support was associated with improved mental health outcomes, regardless of other known 
triggers of negative mental health status. Patients who reported having enough emotional support 
had significantly better mental health well-being than patients who report not having enough 
emotional support. The result of this investigation also showed that social support from a 
physician was significantly correlated with disease activity, organ damage, education, insurance, 
employment status, and visiting a psychiatrist in the past 12 months. The result of this 
investigation also showed that social support from a physician was negatively correlated with 
mental component scores and positively correlated with PHQ9 depression scores. The final aim 
of this study was to determine whether or not physicians’ serving as a source of social support is 
associated with a better mental health well-being for SLE patients. Despite the positive findings 
on social support, social support from a physician yielded unexpected results. Patients who were 
categorized as having social support from a physician were found to be in poorer mental health 
statuses, as measured by the MCS SF-12 and PHQ9 depression score. One potential explanation 
for the findings of this study may be explained in the context that physicians probably tend to 
target patients who they notice are feeling down, anxious or depressed. This approach aligns with 
common physician practices used in treating acute conditions and not chronic illnesses 
(Neurocom, 2012). If physicians commonly ask all of their SLE patients about their mental 
health well-being, there might be a more representative association between social support from 
a physician and patient mental health well-being.  
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Study Strengths  
First, the strength of this study lies on its originality. To the best of our knowledge, no other 
studies measuring the impact of social support from a physician on patient mental health well-
being is available. Knowledge from this study can provide key information and insight into SLE 
disease management. Second, the use of validated instruments of measures in the analysis of 
mental health and depression strengthens results. Study findings are comparable to previous 
literature using these same instruments. Finally, the gender and racial makeup of this study is 
similar to that described by epidemiologic studies with a large number of SLE patients 
(Hochberg, 1997).  
 
Study Limitations  
The results of this study should be interpreted with caution. Using secondary data that was 
not designed to address the research questions, it is not possible to determine whether or not 
physician support predated SLE patient health outcomes, including depression or organ damage. 
This study was also unable to determine the baseline mental health assessment of the patients 
before physician support was utilized. A longitudinal study would allow us to establish whether 
evidence of poor mental health by the patient facilitated social support from a physician or 
whether social support from a physician was provided as a preemptive strike against poor mental 
health. Furthermore, this study was unable to rule out recall bias. The data used is self-reported 
and the longest recall period was 12 months. Lupus patients often experience what is known as a 
“lupus fog,” having feelings of confusion, fatigue, memory impairment and the inability to 
express their thoughts (Sterling et al. , 2014). Comparatively, a long recall would be hard for 
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non-SLE patients to completely adhere to because memory is fallible. Finally, measures of 
comparison for mental component scores on the SF-12 is not optimized for this analysis. 
Theoretically, an SLE patient should have a lower mental health score compared to the general 
United States population average. The score of 50 on the MCS SF-12 is an average of healthy 
and acutely or chronically ill patients; those with severe health issues are skewing this average 
score downward. It may be more feasible to find the average mental component score of SLE 
patients to better understand the severity of a patient’s mental health.  
 
Future Research  
Further research and attention to the association of social support and SLE patient mental 
health well-being are needed.  Our shortcomings suggest that a longitudinal study may be of 
great benefit when exploring the relationship of social support from a physician and mental 
health well-being. Since the data used in this study is derived from the 3rd wave of the GOAL 
cohort data collection, future studies should look at how measured mental health outcomes 
changed over time.  By examining the role if social support from a physician, initiatives to 
increase better mental well-being in SLE patients can be developed. Studies that compare the 
role that social support from a physician has on the mental health status of SLE patients to other 
chronic diseases, like obesity, may provide additional knowledge on the healthcare provider’s 
social support in health. Such studies may give those unfamiliar with SLE, physicians and the 
general public alike, a benchmark for understanding the importance of social support. If the role 
of social support from physicians on SLE patient is found to be different than that of obese 
patient, better disease management techniques can be implemented across different diseases.  
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Public health Relevance  
It is of public health interest to improve physician practices for SLE patients.  The SLE 
community is unique in that disease activity, etiology and symptoms are so complex that it takes 
more resources for disease management.  The findings of this study suggest that physicians 
should ensure that patients have an adequate amount of emotional support for a better mental 
health well-being.  Regardless of whether having enough emotional or social support predates 
the mental health state in question, physicians should work towards providing emotional support 
for SLE patients.  Fluctuation in disease activity can bring about unstable mental health states 
that physicians should be conscious about when providing care.  Implementing cross trainings 
between non mental health physicians and mental health professionals may lead to a better 
understanding of how to engage SLE patients on an emotional level.  Physicians should also 
work on techniques to better serve patients of low SES (annual income, employment status and 
education level).  Limitations in access to healthcare that accompanies a low SES should prompt 
physicians to adjust disease management accordingly. Cultural sensitivity trainings may be of 
benefit to physicians in understanding the varying experiences of patients and providing 
individualized care.  
 
Conclusion  
The findings of this study show that emotional or social support is associated to the 
mental health well-being of SLE patients.  SLE patients who have enough emotional or social 
support were found to have above normal general mental health and less depression. Patients 
who have social support from a physician were found to have below normal general mental 
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health and moderate or severe depression. There is a need for more robust studies to examine the 
exact role social support from physician’s play in patient’s mental health well-being.  
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